drugset / Trial / NCT06566989

A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)

NCT06566989

NaSingle-groupOpen-labelTreatment

Summary

This is a study of opevesostat in healthy adult male participants. The purpose of this study is to understand the absorption, distribution, metabolism, and elimination of opevesostat in humans, as well as its pharmacokinetics (PK), metabolic profile, and safety and tolerability.

Timeline

Start
2024-09-19
Primary completion
2024-10-17
Completion
2024-10-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Opevesostat Small molecule Oral
Background Fludrocortisone Other / unclassified 0.05 mg
Background Prednisone Other / unclassified 5 mg